Safety evaluation of calcium L-methylfolate
- PMID: 31673504
- PMCID: PMC6816227
- DOI: 10.1016/j.toxrep.2019.09.012
Safety evaluation of calcium L-methylfolate
Abstract
Calcium L-methylfolate (L-5-MTHF-Ca; CAS Number 151533-22-1) is a source of folate and an alternative to folic acid for use in human food and food supplements. The safety of L-5-MTHF-Ca was evaluated by testing for genotoxicity, subchronic and prenatal developmental toxicity. In in vitro assays L-5-MTHF-Ca was not mutagenic and did not induce other chromosomal events. Additionally, L-5-MTHF-Ca was not genotoxic in the in vivo micronucleus test nor did it induce DNA damage in rat liver cells. In a subchronic toxicity study, rats administered up to 400 mg/kg bw/day of L-5-MTHF-Ca via oral gavage for 13 weeks had no treatment-related mortalities, and no treatment-related effects were identified on behaviour, body weight, food consumption, ophthalmology, haematology, or organ weights. No treatment-related macroscopic or histopathological findings were observed. Calcium and sodium levels increased with increasing dosage, however the slight increases were within historical control ranges and reversible after the recovery period. L-5-MTHF-Ca is neither teratogenic nor embryotoxic. Based on the results of the in vitro and in vivo studies, the safe use of L-5-MTHF-Ca as an ingredient in foods is supported. The no observed adverse effect level was the highest dose in the subchronic toxicity study, i.e. 400 mg/kg bw/day for male and female rats.
Keywords: 5-MTHF, 5-methyltetrahydrofolate; ANOVA, analysis of variance; BaP, benzo[a]pyrene; Calcium L-methylfolate; Developmental toxicity; EFSA, European Food Safety Authority; GD, gestation day; GLP, Good Laboratory Practice; GRAS, generally recognized as safe; Genotoxicity; HPLC, High Performance Liquid Chromatography; JECFA, Joint FAO/WHO Expert Committee on Food Additives; L-5-MTHF-Ca; L-5-MTHF-Ca, calcium L-methylfolate; MTT, 3-[45-dimethylthiazole-2-yl]-2,5-diphenylbromide; NNG, net grains/nucleus; NOAEL, No Observed Adverse Effect Level; OECD, Organisation for Economic Co-operation and Development; TFT, 5-trifluorothymidine; Toxicity; USP, United States Pharmacopeia; WE-I, Williams E medium-Incomplete; bw, body weight.
© 2019 The Authors.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Dietary safety of cycloastragenol from Astragalus spp.: subchronic toxicity and genotoxicity studies.Food Chem Toxicol. 2014 Feb;64:322-34. doi: 10.1016/j.fct.2013.11.041. Epub 2013 Dec 4. Food Chem Toxicol. 2014. PMID: 24316212
-
Safety evaluation of Whole Algalin Protein (WAP) from Chlorella protothecoides.Food Chem Toxicol. 2013 Sep;59:34-45. doi: 10.1016/j.fct.2013.05.035. Epub 2013 Jun 1. Food Chem Toxicol. 2013. PMID: 23733102
-
Characterisation and toxicological assessment of Neutral Methacrylate Copolymer for GRAS evaluation.Regul Toxicol Pharmacol. 2013 Dec;67(3):392-408. doi: 10.1016/j.yrtph.2013.08.019. Epub 2013 Sep 5. Regul Toxicol Pharmacol. 2013. PMID: 24012708 Review.
-
Conversion of calcium-l-methylfolate and (6S)-5-methyltetrahydrofolic acid glucosamine salt into dietary folate equivalents.EFSA J. 2022 Aug 24;20(8):e07452. doi: 10.2903/j.efsa.2022.7452. eCollection 2022 Aug. EFSA J. 2022. PMID: 36034319 Free PMC article.
-
Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Food Chem Toxicol. 2008. PMID: 18328408 Review.
Cited by
-
Biological, dietetic and pharmacological properties of vitamin B9.NPJ Sci Food. 2025 Mar 13;9(1):30. doi: 10.1038/s41538-025-00396-w. NPJ Sci Food. 2025. PMID: 40075081 Free PMC article. Review.
-
Calcium l-methylfolate as a source of folate added for nutritional purposes to infant and follow-on formula, baby food and processed cereal-based food.EFSA J. 2020 Jan 17;18(1):e05947. doi: 10.2903/j.efsa.2020.5947. eCollection 2020 Jan. EFSA J. 2020. PMID: 32626499 Free PMC article.
-
Association between serum 5-methyltetrahydrofolate and homocysteine in Chinese hypertensive participants with different MTHFR C677T polymorphisms: a cross-sectional study.Nutr J. 2022 May 13;21(1):29. doi: 10.1186/s12937-022-00786-w. Nutr J. 2022. PMID: 35562805 Free PMC article. Clinical Trial.
-
Variations in folate prescriptions for patients with the MTHFR genetic polymorphisms: A case series study.Explor Res Clin Soc Pharm. 2023 May 8;10:100277. doi: 10.1016/j.rcsop.2023.100277. eCollection 2023 Jun. Explor Res Clin Soc Pharm. 2023. PMID: 37228355 Free PMC article.
-
Women Taking a Folic Acid Supplement in Countries with Mandatory Food Fortification Programs May Be Exceeding the Upper Tolerable Limit of Folic Acid: A Systematic Review.Nutrients. 2022 Jun 29;14(13):2715. doi: 10.3390/nu14132715. Nutrients. 2022. PMID: 35807899 Free PMC article.
References
-
- Bailey L.B., Gregory J.F. Folate metabolism and requirements. J. Nutr. 1999;129:779–782. - PubMed
-
- Shrubsole M.J., Jin F., Dai Q., Shu X.O., Potter J.D., Hebert J.R., Gao Y.T., Zheng W. Dietary folate intake and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Res. 2001;61:7136–7141. - PubMed
-
- Robinson K., Arheart K., Refsum H., Brattström L., Boers G., Ueland P., Rubba P., Palma-Reis R., Meleady R., Daly L., Witteman J., Graham I. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation. 1998;97:437–443. - PubMed
-
- Witthöft C.M., Forssén K., Johannesson L., Jägerstad M. Folates - food sources, analyses, retention and bioavailability. Näringsforskning. 1999;43:138–146.
LinkOut - more resources
Full Text Sources
Medical